Elena A. Netreba

ORCID: 0000-0002-0485-3612 · 7 papers in corpus
observational 2023
·doi:10.17816/jowd487470

BACKGROUND: An in-depth study of the pathogenesis of adenomyosis and the development of new therapeutic approaches are extremely relevant. Atosiban, a competitive oxytocin receptor antagonist, may be a promising drug with a potential therap…

observational 2023
·doi:10.17816/jowd346683

BACKGROUND: Patients with endometriosis-associated pain syndrome in combination with anxiety or depression have lower treatment effectiveness and satisfaction with both the disease itself and the pain syndrome compared to patients with pain…

review 2022
·doi:10.17116/repro20222802125

Распространенность аденомиоза не имеет тенденции к снижению, и все чаще это заболевание выявляется у молодых женщин, не осуществивших репродуктивную функцию, в связи с чем необходимо дальнейшее изучение патогенеза аденомиоза, а поиск новых…

diagnostic-accuracy 2021
·doi:10.17816/jowd83066

BACKGROUND: There are currently no uniform standards for adenomyosis diagnosis, so the search for the most informative methods is an urgent task. This article presents modern views on the diagnosis of adenomyosis and the role of ultrasound …

review 2021
·doi:10.17816/jowd57192

The prevalence of genital endometriosis and adenomyosis, in particular, is tending to increase. The lack of a complete understanding of the pathogenetic mechanisms and multifactorial causes of adenomyosis, the low effectiveness of existing …

2019
·doi:10.17116/repro20192506186
2019
·doi:10.17116/repro20192503134